FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20240327E00456
1. Date of relevant event: 22/03/2024
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 01801
4. Name of listed corporation: Innovent Biologics, Inc. 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 1,622,582,897
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Yu
(Other names) De-Chao Michael
10. Name of director (Chinese):  
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
11031The number of shares in which you are interested has increased because:
you became the holder of, wrote or issued equity derivatives under which (choose one):
you have a right to take the underlying shares
 
 
2101Beneficial owner
 
3,726,000         
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position126,400,2487.79
Short position371,7470.02
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position130,126,2488.02
Short position371,7470.02
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2101Beneficial owner
Long position108,703,653
Short position371,747
2307Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position9,000,000
2307Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position12,422,595
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Long position
4105Unlisted derivatives - Physically settled
  HKD0    2,754,000
Long position
4105Unlisted derivatives - Physically settled
22/03/202422/03/2034HKD1HKD40.240  972,000
Long position
4105Unlisted derivatives - Physically settled
  HKD0    2,430,000
Long position
4105Unlisted derivatives - Physically settled
30/03/202330/03/2033HKD1HKD38.390  1,620,000
Long position
4105Unlisted derivatives - Physically settled
  HKD0    2,032,334
Long position
4105Unlisted derivatives - Physically settled
30/03/202230/03/2032HKD1HKD30.600  1,354,889
Long position
4105Unlisted derivatives - Physically settled
  HKD0    725,000
Long position
4105Unlisted derivatives - Physically settled
30/03/202130/03/2031HKD1HKD78.200  1,035,714
Long position
4105Unlisted derivatives - Physically settled
  HKD0    362,500
Long position
4105Unlisted derivatives - Physically settled
15/04/202015/04/2030HKD1HKD33.950  2,071,429
Long position
4105Unlisted derivatives - Physically settled
  HKD0    1,380,360
Long position
4105Unlisted derivatives - Physically settled
15/03/201915/03/2029HKD1HKD28.300  4,142,857
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
   
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
Yu Tong Family Irrevocable TrustAddresses of individuals are not displayed.
5103Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position9,000,000
Madrone Grove Dynasty TrustAddresses of individuals are not displayed.
5103Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position6,211,298
Jenelope Dynasty TrustAddresses of individuals are not displayed.
5103Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position6,211,297
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: In Box 24, the 3,726,000 shares represent the sum of (1) the 972,000 shares to be subscribed upon full exercise of the options granted under the Post-IPO ESOP of the Company on 22 March 2024, and (2) the 2,754,000 shares to be issued upon full vesting of the restricted shares granted under the 2020 RS Plan of the Company on 22 March 2024, the grant of which is subject to independent Shareholders' approval at the Company's AGM on 21 June 2024.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 27/03/2024
(dd/mm/yyyy)